Matthew D. Figley

1.3k total citations
12 papers, 680 citations indexed

About

Matthew D. Figley is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Matthew D. Figley has authored 12 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Matthew D. Figley's work include Amyotrophic Lateral Sclerosis Research (4 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Matthew D. Figley is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (4 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Matthew D. Figley collaborates with scholars based in United States. Matthew D. Figley's co-authors include Aaron DiAntonio, Aaron D. Gitler, Gregor Bieri, J. Paul Taylor, Regina‐Maria Kolaitis, Jeffrey Milbrandt, Xiao‐Dong Fang, Steven Finkbeiner, Zamia Diaz and James Shorter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Neuroscience.

In The Last Decade

Matthew D. Figley

12 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew D. Figley United States 10 429 230 103 102 90 12 680
Timothy A. Bolger United States 13 782 1.8× 58 0.3× 52 0.5× 121 1.2× 56 0.6× 16 915
Chiu-Hui Huang Taiwan 8 494 1.2× 185 0.8× 99 1.0× 110 1.1× 15 0.2× 12 749
César Payán‐Gómez Colombia 13 281 0.7× 102 0.4× 27 0.3× 78 0.8× 33 0.4× 48 557
Xiuyin Teng United States 8 486 1.1× 69 0.3× 98 1.0× 374 3.7× 42 0.5× 8 667
Slobodanka Orolicki Germany 8 331 0.8× 219 1.0× 51 0.5× 146 1.4× 15 0.2× 11 537
Vitaliy V. Bondar United States 9 292 0.7× 111 0.5× 133 1.3× 75 0.7× 41 0.5× 10 590
J. Gavin Daigle United States 7 451 1.1× 291 1.3× 47 0.5× 85 0.8× 186 2.1× 9 670
Victor M. Miller United States 8 745 1.7× 119 0.5× 130 1.3× 376 3.7× 50 0.6× 8 895
Uri Nimrod Ramírez-Jarquín Mexico 10 278 0.6× 146 0.6× 31 0.3× 149 1.5× 77 0.9× 14 480
Evgeny Shlevkov United States 8 429 1.0× 110 0.5× 184 1.8× 113 1.1× 10 0.1× 10 631

Countries citing papers authored by Matthew D. Figley

Since Specialization
Citations

This map shows the geographic impact of Matthew D. Figley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Figley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Figley more than expected).

Fields of papers citing papers by Matthew D. Figley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Figley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Figley. The network helps show where Matthew D. Figley may publish in the future.

Co-authorship network of co-authors of Matthew D. Figley

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Figley. A scholar is included among the top collaborators of Matthew D. Figley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Figley. Matthew D. Figley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Mirescu, Christian, Borislav Dejanovic, Frederick W. Gergits, et al.. (2024). Pharmacological and functional characterization of the first small molecule TREM2 agonist, VG‐3927, for the treatment of Alzheimer’s disease. Alzheimer s & Dementia. 20(S6). 4 indexed citations
2.
Gergits, Frederick W., Abigail J. Renoux, Matthew D. Figley, et al.. (2022). VGL101 Rescues CSF1R Dysfunction in Human Microglia And Macrophages: Evaluation of In Vitro Trem2 Agonism in Models Of A CSF1R‐Dependent Leukodystrophy. Alzheimer s & Dementia. 18(S3). 4 indexed citations
3.
Shen, Chen, Pengfei Zhang, Xianrong Mao, et al.. (2021). Multiple domain interfaces mediate SARM1 autoinhibition. Proceedings of the National Academy of Sciences. 118(4). 41 indexed citations
4.
Zhu, Jian, Amy Strickland, Kwang Woo Ko, et al.. (2021). Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss. Cell Reports. 37(3). 109872–109872. 25 indexed citations
5.
DiAntonio, Aaron, Jeffrey Milbrandt, & Matthew D. Figley. (2021). The SARM1 TIR NADase: Mechanistic Similarities to Bacterial Phage Defense and Toxin-Antitoxin Systems. Frontiers in Immunology. 12. 752898–752898. 13 indexed citations
6.
Figley, Matthew D. & Aaron DiAntonio. (2020). The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease. Current Opinion in Neurobiology. 63. 59–66. 93 indexed citations
7.
Sasaki, Yo, Thomas M. Engber, Robert Hughes, et al.. (2020). cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons. Experimental Neurology. 329. 113252–113252. 73 indexed citations
8.
Figley, Matthew D., Gregor Bieri, Regina‐Maria Kolaitis, J. Paul Taylor, & Aaron D. Gitler. (2014). Profilin 1 Associates with Stress Granules and ALS-Linked Mutations Alter Stress Granule Dynamics. Journal of Neuroscience. 34(24). 8083–8097. 117 indexed citations
9.
Figley, Matthew D., Anna Thomas, & Aaron D. Gitler. (2013). Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis. Neurobiology of Aging. 35(4). 936.e1–936.e4. 15 indexed citations
10.
Figley, Matthew D. & Aaron D. Gitler. (2013). Yeast genetic screen reveals novel therapeutic strategy for ALS. PubMed. 1(1). e24420–e24420. 21 indexed citations
11.
Figley, Matthew D., Sami J. Barmada, Emily A. Scarborough, et al.. (2012). Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nature Genetics. 44(12). 1302–1309. 207 indexed citations
12.
Bonneh‐Barkay, Dafna, Huichao Zou, Christian Niyonkuru, et al.. (2010). YKL-40 Expression in Traumatic Brain Injury: An Initial Analysis. Journal of Neurotrauma. 27(7). 1215–1223. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy A. Bolger Breakdown of academic impact, for papers by Chiu-Hui Huang Breakdown of academic impact, for papers by César Payán‐Gómez Breakdown of academic impact, for papers by Xiuyin Teng Breakdown of academic impact, for papers by Slobodanka Orolicki Breakdown of academic impact, for papers by Vitaliy V. Bondar Breakdown of academic impact, for papers by J. Gavin Daigle Breakdown of academic impact, for papers by Victor M. Miller Breakdown of academic impact, for papers by Uri Nimrod Ramírez-Jarquín Breakdown of academic impact, for papers by Evgeny Shlevkov
Rankless by CCL
2026